Pricing Log in Create free account
Saturday 17 October 2026 Export COLL’s income statement to Excel — free account

Collegium Pharmaceutical, Inc.

COLL Healthcare Drug Manufacturers Specialty & Generic

Collegium Pharmaceutical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $780.6 million, up 23.6% from fiscal 2024. In the quarter to June 2026, revenue grew 6.32%, EPS fell 221.1%, free cash flow fell 2.14% and total debt rose 32.6%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

23.19 0.01 +0.04%
Market cap
$754.6M
P/E
15.2×
Fwd P/E
12.5×
Dividend yield
—
F-score
7/9
Altman Z
1.58
Beneish M
−3.32
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Collegium Pharmaceutical, Inc. (COLL) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Collegium Pharmaceutical, Inc. (COLL) trades at a P/E ratio of 15.2×. Over the past ten years it has ranged from 0.0× (September 2023) to 114× (December 2023); the current reading is higher than 77% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 19.2× and below the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 23.2× 72.92%
FY2024 13.4× (36.98%)
FY2023 21.2× —
FY2022 0.0× —
FY2021 9.3× (64.27%)
FY2020 26.0× —
FY2019 0.0× —
FY2018 0.0× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 23.7× 69.56%
Mar 2026 14.0× (39.73%)
Dec 2025 23.2× 22.40%
Sep 2025 18.9× (27.08%)
36 more quarters

Against its own ten years

Low 0.0× High 114×
Ten-year median 0.0×
Current reading's percentile 46

P/E ratio against peers

Company P/E ratio
HROW Harrow, Inc. compare n/m
AQST Aquestive Therapeutics, Inc. compare n/m
EVO Evotec AG compare n/m
TLRY Tilray Brands, Inc. compare n/m
EOLS Evolus, Inc. compare n/m
IRWD Ironwood Pharmaceuticals, Inc. compare 4.4×
AMPH Amphastar Pharmaceuticals, Inc. compare 14.9×
COLL Collegium Pharmaceutical, Inc. 15.2×
CRON Cronos Group Inc. compare 16.1×
Drug Manufacturers Specialty & Generic industry median 19.2×
Healthcare sector median 23.0×
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on COLL